88
Participants
Start Date
January 30, 2014
Primary Completion Date
March 20, 2018
Study Completion Date
June 30, 2026
Positron emission tomography (PET)
PET will be performed at baseline and on day 15
Trastuzumab
8 mg/kg loading dose, then 6 mg/kg every 3 weeks, IV
Pertuzumab
840 mg as a loading dose, then 420 mg every 3 weeks, IV
Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, Washington D.C.
Lineberger Comprehensive Cancer Center, Chapel Hill
University of Alabama Comprehensive Cancer Center, Birmingham
Vanderbilt University, Nashville
Indiana University Simon Cancer Center, Indianapolis
Mayo Clinic, Rochester
Baylor College of Medicine, Houston
The University of Texas MD Anderson Cancer Center, Houston
Fred Hutchinson Cancer Research Center - University of Washington, Seattle
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Collaborators (1)
Translational Breast Cancer Research Consortium
OTHER
Genentech, Inc.
INDUSTRY
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OTHER